Program Schedule

182
Update on Respiratory Viruses in Immunocompromised Patients

Saturday, October 11, 2014: 10:30 AM-12:00 PM
Room: The Pennsylvania Convention Center: 114

Learning Objectives:

At the conclusion of this session, participants will be able to:

  • describe at least two disease associations beyond acute respiratory illness associated with respiratory virus infection
  • list new therapeutic agents in development for treatment of respiratory viruses
  • explain the current approaches to prevent spread of respiratory viruses within the hospital setting

Target Audience: Scientists, Researchers, Microbiologists, Lab personnel, Investigators, Infectious diseases physicians, Infection preventionists, Fellows, Clinicians, Academicians

Tracks: Adult ID, Epidemiology and Infection Control

Moderator:  Ajit Limaye, MD, FIDSA, University of Washington

Presentations:
10:30 AM
New Therapeutic Agents
Michael Ison, MD MS
11:00 AM
Impact Beyond Acute Illness
Michael Boeckh, MD
11:30 AM
Infection Control Issues
Mini Kamboj, MD

CME Credits: Maximum of 1.5 hours of AMA PRA Category 1 CreditTM

ACPE Credits:

ACPE Number:

Disclosures:

A. Limaye, Genentech: Consultant and Grant Investigator, Consulting fee
Merck: Grant Investigator, Consulting fee
Viropharma: Grant Investigator, Contracted research
Astellas: Grant Investigator, Contracted research
BioRad: Consultant, Consulting fee

M. Ison, Cellex: Consultant and Investigator, Research support
Chimerix: Consultant and Investigator, Research support
Crucell: Consultant and Investigator, Consulting fee and Research support
GlaxoSmithKlein: Consultant and Investigator, Research support
NexBio: Consultant, DSMB Member and Investigator, DSMB Fee and Research support
Visterra: Consultant, Consulting fee
Biota: Consultant and DSMB, DSMB Fee

M. Boeckh, Genentech/Roche: Consultant and Investigator, Consulting fee and Research grant
Gilead Sciences: Consultant and Investigator, Consulting fee and Research support
GSK: Consultant and Investigator, Consulting fee and Research support
Ansun Biopharma: Investigator, Research support

M. Kamboj, None

See more of: Symposium

Findings in the abstracts are embargoed until 12:01 a.m. EDT, Oct. 8th with the exception of research findings presented at the IDWeek press conferences.

Sponsoring Societies:

© 2014, idweek.org. All Rights Reserved.

Follow IDWeek